Halladay Benjamin bought ESPR
March 14, 2024 · Form 4 insider transaction
Halladay Benjamin bought 200,000 shares of Esperion Therapeutics, Inc. Common Stock at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
200,000
Price
$0.00
Total value
N/A
InsiderHalladay Benjamin
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 14, 2024
Filing dateMarch 15, 2024
Shares owned after200,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be June 15, 2024.